Nasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (20592002)
This publication has 49 references indexed in Scilit:
- Regulation of TH17 cells in the mucosal surfacesJournal of Allergy and Clinical Immunology, 2009
- Interleukin-17A Mediates Acquired Immunity to Pneumococcal ColonizationPLOS Pathogens, 2008
- Protection, systemic IFNγ, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural hostVeterinary Research, 2008
- Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX? adjuvant in women with cervical intraepithelial neoplasiaVaccine, 2004
- NALT- versus PEYER'S-patch-mediated mucosal immunityNature Reviews Immunology, 2004
- ISCOMATRIX™ adjuvant: an adjuvant suitable for use in anticancer vaccinesVaccine, 2004
- Mouse and human dendritic cell subtypesNature Reviews Immunology, 2002
- The Role of Interleukin-6 in Mucosal IgA Antibody Responses in VivoScience, 1994
- Lymphokine Control of In Vivo Immunoglobulin Isotype SelectionAnnual Review of Immunology, 1990
- Identification of a 16,600-dalton outer membrane protein on nontypeable Haemophilus influenzae as a target for human serum bactericidal antibody.Journal of Clinical Investigation, 1986